BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25775405)

  • 1. Derricin and derricidin inhibit Wnt/β-catenin signaling and suppress colon cancer cell growth in vitro.
    Fonseca BF; Predes D; Cerqueira DM; Reis AH; Amado NG; Cayres MC; Kuster RM; Oliveira FL; Mendes FA; Abreu JG
    PLoS One; 2015; 10(3):e0120919. PubMed ID: 25775405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoquercitrin suppresses colon cancer cell growth in vitro by targeting the Wnt/β-catenin signaling pathway.
    Amado NG; Predes D; Fonseca BF; Cerqueira DM; Reis AH; Dudenhoeffer AC; Borges HL; Mendes FA; Abreu JG
    J Biol Chem; 2014 Dec; 289(51):35456-67. PubMed ID: 25359775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of 2-hydroxycinnamaldehyde for human colon cancer cells through suppression of β-catenin signaling.
    Lee MA; Park HJ; Chung HJ; Kim WK; Lee SK
    J Nat Prod; 2013 Jul; 76(7):1278-84. PubMed ID: 23855266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines.
    Jingushi K; Takahashi-Yanaga F; Yoshihara T; Shiraishi F; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
    Biochem Pharmacol; 2012 Jan; 83(1):47-56. PubMed ID: 22005519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/β-catenin signaling.
    Wu K; Yang Q; Mu Y; Zhou L; Liu Y; Zhou Q; He B
    Int J Oncol; 2012 Jul; 41(1):292-8. PubMed ID: 22469784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisleuconothine A, a bisindole alkaloid, inhibits colorectal cancer cell in vitro and in vivo targeting Wnt signaling.
    Kong LM; Feng T; Wang YY; Li XY; Ye ZN; An T; Qing C; Luo XD; Li Y
    Oncotarget; 2016 Mar; 7(9):10203-14. PubMed ID: 26862734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine acts as a natural inhibitor of Wnt/β-catenin signaling--identification of more active 13-arylalkyl derivatives.
    Albring KF; Weidemüller J; Mittag S; Weiske J; Friedrich K; Geroni MC; Lombardi P; Huber O
    Biofactors; 2013; 39(6):652-62. PubMed ID: 23982892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tussilagone suppresses colon cancer cell proliferation by promoting the degradation of β-catenin.
    Li H; Lee HJ; Ahn YH; Kwon HJ; Jang CY; Kim WY; Ryu JH
    Biochem Biophys Res Commun; 2014 Jan; 443(1):132-7. PubMed ID: 24269588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice.
    Waaler J; Machon O; Tumova L; Dinh H; Korinek V; Wilson SR; Paulsen JE; Pedersen NM; Eide TJ; Machonova O; Gradl D; Voronkov A; von Kries JP; Krauss S
    Cancer Res; 2012 Jun; 72(11):2822-32. PubMed ID: 22440753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
    Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
    J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer.
    Qu Y; Olsen JR; Yuan X; Cheng PF; Levesque MP; Brokstad KA; Hoffman PS; Oyan AM; Zhang W; Kalland KH; Ke X
    Nat Chem Biol; 2018 Jan; 14(1):94-101. PubMed ID: 29083417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-proliferative activity of hydnocarpin, a natural lignan, is associated with the suppression of Wnt/β-catenin signaling pathway in colon cancer cells.
    Lee MA; Kim WK; Park HJ; Kang SS; Lee SK
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5511-4. PubMed ID: 24018191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C ζ is a positive modulator of canonical Wnt signaling pathway in tumoral colon cell lines.
    Luna-Ulloa LB; Hernández-Maqueda JG; Santoyo-Ramos P; Castañeda-Patlán MC; Robles-Flores M
    Carcinogenesis; 2011 Nov; 32(11):1615-24. PubMed ID: 21859831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
    Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
    Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chalcone Derivative CX258 Suppresses Colorectal Cancer via Inhibiting the TOP2A/Wnt/β-Catenin Signaling.
    Chen X; Lv X; Gao L; Liu J; Wang W; Guo L; Frasinyuk MS; Zhang W; Watt DS; Liu C; Liu X
    Cells; 2023 Mar; 12(7):. PubMed ID: 37048139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
    Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
    Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt/β-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells.
    Kang YJ; Park HJ; Chung HJ; Min HY; Park EJ; Lee MA; Shin Y; Lee SK
    Mol Pharmacol; 2012 Aug; 82(2):168-77. PubMed ID: 22550094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardamonin suppresses the proliferation of colon cancer cells by promoting β-catenin degradation.
    Park S; Gwak J; Han SJ; Oh S
    Biol Pharm Bull; 2013; 36(6):1040-4. PubMed ID: 23538439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Wnt signaling activity for growth suppression induced by quercetin in 4T1 murine mammary cancer cells.
    Kim H; Seo EM; Sharma AR; Ganbold B; Park J; Sharma G; Kang YH; Song DK; Lee SS; Nam JS
    Int J Oncol; 2013 Oct; 43(4):1319-25. PubMed ID: 23900432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.